All Psychedelics Articles

Filters
Clear all
All
Artificial Intelligence
Biotech
Cannabis
Carbon
Climate Tech
Crypto
Defense Tech
Electric Vehicles
Energy
Food Tech
Gaming
Longevity
Mining
Nuclear
Psychedelics
Quantum Computing
Robotics
Space
Technology
Venture Capital
Article Tags
Search by Keywords
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
FDA Grants Priority Review For MDMA
Psychedelics

FDA Grants Priority Review For MDMA

The United States FDA has granted MDMA assisted therapy a priority review to Lykos Therapeutics.
February 15, 2024
Biotech
Psychedelics
Lykos Therapeutics Launches With $100 Million For MDMA Treatments
Psychedelics

Lykos Therapeutics Launches With $100 Million For MDMA Treatments

MAPS has officially launched Lykos Therapeutics as a for profit biotechnology company to advance MDMA assisted therapies.
January 7, 2024
Biotech
Psychedelics
Venture Capital
COMPASS Pathways And Greenbrook Are Partnering Up For Psychedelic Therapies
Psychedelics

COMPASS Pathways And Greenbrook Are Partnering Up For Psychedelic Therapies

Psychedelic biotechnology company COMPASS Pathways (NASDAQ:CMPS) has entered into a new multi year research collaboration with Greenbrook TMS (NASDAQ:GNBH).
January 6, 2024
Biotech
Public Companies
Psychedelics
atai Life Sciences is Taking a Psychedelic Investing Trip
Psychedelics

atai Life Sciences is Taking a Psychedelic Investing Trip

atai Life Sciences (NASDAQ: ATAI) has announced they will invest $50 million into psychedelic drug developer Beckley Psytech
January 5, 2024
Biotech
Psychedelics
Public Companies
At Home Ketamine Therapeutics For Fibromyalgia
Psychedelics

At Home Ketamine Therapeutics For Fibromyalgia

Silo Pharma (NASDAQ: SILO) has received regulatory approval to advance their novel time release ketamine implant into preclinical research
January 1, 2024
Biotech
Public Companies
Psychedelics
Australia Has Its First Dedicated Psychedelic Clinic
Psychedelics

Australia Has Its First Dedicated Psychedelic Clinic

Incannex Healthcare (NASDAQ: IXHL) subsidiary Clarion Clinics has received regulatory approval to begin to administer psychedelic assisted therapies.
December 26, 2023
Public Companies
Biotech
MDMA Assisted Therapy Could Be Closer Than Ever
Psychedelics

MDMA Assisted Therapy Could Be Closer Than Ever

MAPS Public Benefit Corporation has just filed a New Drug Application with the FDA for MDMA assisted therapy to treat post traumatic stress disorder (PTSD).
December 12, 2023
Biotech
Psychedelics
Gilgamesh Psychedelic Trial Shows Promise in Mental Health and Beyond
Psychedelics

Gilgamesh Psychedelic Trial Shows Promise in Mental Health and Beyond

Gilgamesh Pharmaceuticals has announced positive results from their Phase 1 trial of GM-2505, a novel 5-HT2A receptor agonist.
December 11, 2023
Biotech
Venture Capital
Psychedelics
Cybin is Seeing Positive Results For Psychedelics in Phase II Clinical Trials
Psychedelics

Cybin is Seeing Positive Results For Psychedelics in Phase II Clinical Trials

Cybin (NYSE: CYBN) has announced positive data from their Phase II clinical trial for their novel psilocybin analog CYB003.
November 30, 2023
Biotech
Public Companies
Harvard Lands $16 Million For Psychedelic Research
Psychedelics

Harvard Lands $16 Million For Psychedelic Research

Harvard University has received $16 million in new philanthropic funding to research psychedelic compounds for therapeutic potential.
October 21, 2023
Psychedelics
Biotech
No results found.
There are no results with this criteria. Try changing your search.

Discover the world's most disruptive early stage companies with 35,000+ investors.

The markets and trends that matter, made simple.

Join top talent at the world's most respected institutions, companies, and venture capital funds.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.